1. Home
  2. VERA vs VTLE Comparison

VERA vs VTLE Comparison

Compare VERA & VTLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • VTLE
  • Stock Information
  • Founded
  • VERA 2016
  • VTLE 2006
  • Country
  • VERA United States
  • VTLE United States
  • Employees
  • VERA N/A
  • VTLE N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • VTLE
  • Sector
  • VERA Health Care
  • VTLE
  • Exchange
  • VERA Nasdaq
  • VTLE Nasdaq
  • Market Cap
  • VERA 2.5B
  • VTLE 1.1B
  • IPO Year
  • VERA 2021
  • VTLE 2011
  • Fundamental
  • Price
  • VERA $42.01
  • VTLE $27.25
  • Analyst Decision
  • VERA Strong Buy
  • VTLE Hold
  • Analyst Count
  • VERA 9
  • VTLE 13
  • Target Price
  • VERA $53.56
  • VTLE $47.91
  • AVG Volume (30 Days)
  • VERA 683.6K
  • VTLE 1.0M
  • Earning Date
  • VERA 11-07-2024
  • VTLE 11-06-2024
  • Dividend Yield
  • VERA N/A
  • VTLE N/A
  • EPS Growth
  • VERA N/A
  • VTLE N/A
  • EPS
  • VERA N/A
  • VTLE 8.51
  • Revenue
  • VERA N/A
  • VTLE $1,838,745,000.00
  • Revenue This Year
  • VERA N/A
  • VTLE $28.00
  • Revenue Next Year
  • VERA N/A
  • VTLE $9.74
  • P/E Ratio
  • VERA N/A
  • VTLE $3.10
  • Revenue Growth
  • VERA N/A
  • VTLE 22.93
  • 52 Week Low
  • VERA $9.68
  • VTLE $25.85
  • 52 Week High
  • VERA $50.78
  • VTLE $58.30
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • VTLE 42.98
  • Support Level
  • VERA $39.22
  • VTLE $25.85
  • Resistance Level
  • VERA $50.00
  • VTLE $28.36
  • Average True Range (ATR)
  • VERA 2.41
  • VTLE 1.03
  • MACD
  • VERA 0.24
  • VTLE 0.03
  • Stochastic Oscillator
  • VERA 28.53
  • VTLE 28.87

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About VTLE Vital Energy Inc. par value $0.01 per share

Vital Energy is an independent energy company. Its business is focused on the acquisition, exploration, and development of oil and natural gas properties in the Permian Basin of West Texas. The Company has identified one operating segment: exploration and production.

Share on Social Networks: